BridgeBio Pharma, Inc. earnings per share and revenue

BBIO earnings per share for the last quarter are -0.20 USD whereas the estimation was -0.74 USD which accounts for 72.85% surprise. Företagets omsättning för samma period uppgår till 211.12 M USD trots den uppskattade siffran 7.26 M USD. Estimated earnings per share for the next quarter are -1.00 USD, and revenue is expected to reach 4.13 M USD. Also watch annual changes over time to get a bigger picture of BBIO earnings per share and revenue dynamics.